Cognitive Impairment and Neuropsychiatric Manifestations in Parkinson’s disease in Africa: A Systematic Review of Evidence
Objective: To critically appraise and synthesize evidence on the prevalence and clinical correlates of cognitive impairment and neuropsychiatric manifestations among patients with Parkinson’s disease in…Sex-Specific Differences in Parkinson’s Disease: A Retrospective Analysis of over 10,000 Patients from the Paracelsus-Elena Hospital, a Specialized Movement Disorder Clinic in Germany
Objective: To analyze sex differences in PD in a large cohort from a hospital specializing in PD and other movement disorders. Background: Sex differences in…Functional Belly Dancer Dyskinesia Associated with Abdominal Pain: A Case Series
Objective: To describe belly dancer dyskinesia (BDD) presenting as a manifestation of functional movement disorder associated with abdominal pain, and to emphasize the role of…The Effect of Depression on the Cognitive Phenotype in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia.
Objective: To investigate the impact of depression on cognitive functioning in a group of older adults without dementia. Background: Parkinson’s disease (PD) is a neurodegenerative…Depression and Psychosis in military Veterans with Parkinson’s Disease (PD)
Objective: To compare the presence of co-morbid depression in groups of PD Veterans, with and without psychosis. Background: Depression and psychosis are important non motor…Prevalence and Treatment Patterns of Anxiety Symptoms in Parkinson’s Disease
Objective: To examine the prevalence of clinically significant anxiety symptoms, their overlap with depressive symptoms, and associated pharmacologic treatment patterns in Parkinson's disease (PD). Background:…Risk of Serotonin Syndrome in the Combined Use of Selective Monoamine Oxidase B Inhibitors and Serotonin-acting Antidepressants
Objective: We aim to determine the risk of serotonin syndrome with selective monoamine oxidase B inhibitors (MAO-Bi) use, especially when combined with serotonin-acting antidepressants. Background:…Depressive Symptoms and Functional Impairment in Huntington’s Disease A Brazilian Cohort Study
Objective: To investigate the prevalence of psychiatric manifestations in Huntington’s disease (HD) and examine their association with functional disease stages. Background: HD is an autosomal…Affective Symptom Burden in Individuals with Olfactory Dysfunction in the PREDICT-PD Cohort
Objective: To investigate associations between hyposmia (olfactory dysfunction) and affective symptom burden in PREDICT-PD participants. Background: Anxiety, depression, and hyposmia are common non-motor features of…Psychiatric Symptoms and Quality of Life in Huntington’s Disease Evidence from a Brazilian Cohort
Objective: To investigate the association between psychiatric manifestations and perceived quality of life in patients with Huntington’s disease (HD). Background: HD is a progressive neurodegenerative…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 38
- Next Page »